Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Annexon Biosciences Inc.
DescriptionHumanized mAb that inhibits complement component 1 q subcomponent (C1q)
Molecular Target Complement component 1 q subcomponent (C1q)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today